MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Clinical features"

  • 2017 International Congress

    Phenotype of PLP1-related disorder caused by novel mutation: a case report

    N. Kresojevic, I. Petrovic, V. Dobricic, A. Tomic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To illustrate phenotype of PLP1-related disorder caused by a novel mutation. Background: Phenotypes of X-linked PLP1-related disorders vary from severe forms of hypomyelinating leukodystrophy-Pelizaeus–Merzbacher…
  • 2017 International Congress

    Genotype-Phenotype correlations and expansion of the molecular spectrum of AP4M1-related Hereditary Spastic Paraplegia

    S. Efthymiou, C. Bettencourt, V. Salpietro Damiano, H. Houlden (London, United Kingdom)

    Objective: To identify possible novel variants in a HSP family from Greece.  Background: Autosomal recessive hereditary spastic paraplegia (HSP) due to AP4M1 mutations is a…
  • 2017 International Congress

    Effect of Valproic Acid on Dystonia in a patient with Traumatic Brain Injury: a case report.

    N. Fatima (Lahore, Pakistan)

    Objective: Valproic Acid, a branched short chain fatty acid, is widely used as an epileptic drug and mood stabilizer [1]. Its mechanism of action is…
  • 2017 International Congress

    Hereditary spastic paraplegia type 31: a novel splice site donor mutation and intra-familial phenotypic variability

    M. Kamada, T. Kawarai, R. Miyamoto, Y. Tojima, A. Orlacchio, R. Kaji (Kita-gun, Japan)

    Objective: The aim of this study is to reveal molecular pathogenicity and genotype-phenotype correlations in Spastic Paraplegia type 31 (SPG31). Background: Mutations in REEP1 have…
  • 2016 International Congress

    A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)

    A. Orlacchio, M. Mearini, L. Pedace, A. Casella, C. Montecchiani, F. Gaudiello, M. Maurialuisa, R. Massa, C. Caltagirone, R.P. Munhoz, J.L. Pedroso, O.G.P. Barsottini, T. Kawarai (Rome, Italy)

    Objective: This study includes the evaluation of a comprehensive spectrum of neurological features and the mutational screening of the SPG4/SPAST gene in patients with hereditary…
  • 2016 International Congress

    Bristle hair may point to hereditary spastic paraplegia type SPG35/ FAHN

    T.W. Rattay, A.S. Söhn, K.N. Karle, S. Wiethoff, J. Reichbauer, M. Döbler-Neumann, I. Krägeloh-Mann, A. Münchau, B. Wilken, P. Bauer, L. Schöls, R. Schüle (Tübingen, Germany)

    Objective: Finding new phenotypic features or biomarkers in hereditary spastic paraplegia type SPG35 / Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN) to help clinicians to identify this…
  • 2016 International Congress

    A homozygous loss-of-function mutation in DNAJA3 causes hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V)

    T. Kawarai, R. Miyamoto, Y. Kuroda, M. Omoto, M. Ueyama, N. Murakami, T. Furukawa, R. Oki, A. Mori, Y. Osaki, C. Banzrai, H. Nodera, A. Orlacchio, A. Hashiguchi, Y. Higuchi, H. Takashima, T. Kanda, Y. Izumi, Y. Nagai, T. Mitsui, R. Kaji (Tokushima, Japan)

    Objective: To identify a genetic cause for hereditary motor and sensory neuropathy with spastic paraplegia (HMSN type V). Background: Hereditary spastic paraplegia (HSP) constitutes a…
  • 2016 International Congress

    Novel variants in the SACS gene in a first Central-Eastern European family with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)

    M. Schinwelski, M. Krygier, J. Slawek, M. Zuk, M. Rydzanicz, A. Walczak, P. Stawinski, A. Konkel, M. Sildatke-Bauer, R. Ploski, J. Limon (Gdansk, Poland)

    Objective: To present genetics, clinical description and natural history of the disease in four members of a Polish family with novel variants in the SACS…
  • 2016 International Congress

    Are we speaking the same language? A pilot study to evaluate the agreement in clinical phenotyping of children with cerebral palsy

    H. Eggink, D. Kremer, O.F. Brouwer, M.F. Contarino, M.E. van Egmond, A. Elema, K. Folmer, J.F. van Hoorn, L.A. van de Pol, V. Roelfsema, M.A.J. Tijssen (Groningen, Netherlands)

    Objective: The aim of this pilot study was determine the agreement of phenotypical classification of children with cerebral palsy among clinicians. Background: Cerebral palsy (CP)…
  • 2016 International Congress

    Development of the UK hereditary spastic paraplegia registry: Analysis of SPAST patients reveals high rate of psychiatric comorbidities

    V. Chelban, A. Tucci, H. Houlden (Chisinau, Republic of Moldova)

    Objective: To (1) describe the genetic variability, phenotype and epidemiology of spastin mutation in HSP patients (2) create the UK HSP register with a focus…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley